Renaissance Investment Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.7M Sell
25,427
-297
-1% -$143K 2.51% 17
2026
Q1
$12.6M Sell
25,724
-51
-0.2% -$27.7K 2.72% 14
2025
Q4
$14.9M Sell
25,775
-48
-0.2% -$27.1K 3.01% 11
2025
Q3
$12.5M Sell
25,823
-245
-0.9% -$114K 2.54% 18
2025
Q2
$10.6M Sell
26,068
-229
-0.9% -$95.7K 2.29% 20
2025
Q1
$13.1M Sell
26,297
-435
-2% -$236K 3.18% 9
2024
Q4
$13.9M Sell
26,732
-103
-0.4% -$56.6K 2.94% 11
2024
Q3
$16.6M Buy
26,835
+28
+0.1% +$16.6K 3.45% 7
2024
Q2
$14.3M Buy
26,807
+208
+0.8% +$119K 3.1% 7
2024
Q1
$15.5M Buy
26,599
+158
+0.6% +$88.7K 3.55% 5
2023
Q4
$14M Sell
26,441
-153
-0.6% -$74.1K 3.49% 6
2023
Q3
$13.5M Sell
26,594
-244
-0.9% -$130K 3.75% 4
2023
Q2
$14M Sell
26,838
-438
-2% -$236K 3.68% 3
2023
Q1
$15.7M Sell
27,276
-702
-3% -$396K 4.41% 3
2022
Q4
$15.4M Buy
27,978
+19
+0.1% +$10.1K 4.59% 1
2022
Q3
$14.1M Sell
27,959
-328
-1% -$184K 4.4% 3
2022
Q2
$15.4M Sell
28,287
-241
-0.8% -$133K 5.01% 3
2022
Q1
$15.6M Sell
28,528
-1,105
-4% -$635K 4.55% 3
2021
Q4
$19.8M Sell
29,633
-550
-2% -$343K 4.69% 3
2021
Q3
$17.2M Sell
30,183
-46
-0.2% -$25.2K 4.4% 3
2021
Q2
$15.2M Buy
30,229
+19
+0.1% +$8.96K 3.9% 4
2021
Q1
$13.8M Sell
30,210
-442
-1% -$211K 3.8% 4
2020
Q4
$14.3M Sell
30,652
-2,994
-9% -$1.4M 4.2% 4
2020
Q3
$14.9M Sell
33,646
-130
-0.4% -$53.7K 4.94% 4
2020
Q2
$12.2M Sell
33,776
-5,684
-14% -$1.91M 4.51% 4
2020
Q1
$11.2M Buy
39,460
+79
+0.2% +$24.9K 5.29% 3
2019
Q4
$12.8M Sell
39,381
-608
-2% -$184K 4.56% 3
2019
Q3
$11.6M Buy
39,989
+71
+0.2% +$20.3K 4.49% 3
2019
Q2
$11.7M Sell
39,918
-692
-2% -$191K 4.37% 2
2019
Q1
$11.1M Sell
40,610
-2,392
-6% -$595K 4.53% 1
2018
Q4
$9.62M Sell
43,002
-1,657
-4% -$389K 4.61% 2
2018
Q3
$10.9M Sell
44,659
-1,816
-4% -$418K 4.2% 3
2018
Q2
$9.63M Sell
46,475
-235
-0.5% -$49.9K 3.87% 3
2018
Q1
$9.64M Sell
46,710
-514
-1% -$108K 3.9% 3
2017
Q4
$8.97M Sell
47,224
-760
-2% -$146K 3.58% 4
2017
Q3
$9.08M Sell
47,984
-1,741
-4% -$315K 3.8% 2
2017
Q2
$8.68M Sell
49,725
-915
-2% -$154K 3.8% 3
2017
Q1
$7.78M Sell
50,640
-670
-1% -$102K 3.45% 5
2016
Q4
$7.24M Sell
51,310
-579
-1% -$85.4K 3.42% 4
2016
Q3
$8.25M Buy
51,889
+596
+1% +$91.8K 3.96% 3
2016
Q2
$7.58M Sell
51,293
-2
-0% -$295 3.76% 5
2016
Q1
$7.26M Sell
51,295
-260
-0.5% -$34.8K 3.65% 4
2015
Q4
$7.31M Buy
51,555
+635
+1% +$84.7K 3.56% 5
2015
Q3
$6.23M Sell
50,920
-1,595
-3% -$208K 3.24% 7
2015
Q2
$6.81M Sell
52,515
-15
-0% -$1.96K 3.19% 7
2015
Q1
$7.06M Sell
52,530
-623
-1% -$80.3K 3.26% 6
2014
Q4
$6.66M Buy
53,153
+165
+0.3% +$20.1K 3.14% 7
2014
Q3
$6.45M Sell
52,988
-197
-0.4% -$24K 3.11% 5
2014
Q2
$6.28M Buy
53,185
+90
+0.2% +$10.6K 3.05% 6
2014
Q1
$6.38M Sell
53,095
-632
-1% -$75.1K 3.24% 5
2013
Q4
$5.98M Buy
53,727
+1,370
+3% +$136K 3.04% 7
2013
Q3
$4.82M Sell
52,357
-1,185
-2% -$107K 2.68% 10
2013
Q2
$4.53M Buy
+53,542
New +$4.46M 2.58% 11

Other funds holding TMO

Renaissance Investment Group's TMO Position: Q2 2026 in Review

Renaissance Investment Group reduced its Thermo Fisher Scientific (TMO) stake by 1.2% in Q2 2026, selling an estimated $143K and leaving 25,427 shares worth $12.7M. The position accounts for 2.51% of the portfolio, ranked #17.

Renaissance Investment Group first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $19.8M in Q4 2021. 708 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Renaissance Investment Group held 25,427 shares of Thermo Fisher Scientific worth $12.7M as of Q2 2026.
  • Renaissance Investment Group sold 297 Thermo Fisher Scientific shares in Q2 2026, an estimated $143K.
  • Thermo Fisher Scientific made up 2.51% of Renaissance Investment Group's portfolio in Q2 2026, its #17 holding.
  • Renaissance Investment Group first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • Renaissance Investment Group's Thermo Fisher Scientific position peaked at $19.8M in Q4 2021.
  • 708 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Renaissance Investment Group's 13F filing for Q2 2026, filed 8 Jul 2026.